Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Clinical trial NCT06819215 · RECRUITING

Trial details

NCT number: NCT06819215
Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Neoplasms Neoplasms, Breast Tumor PARP Ovarian Neoplasms Prostatic Cancer Pancreatic Cancer Breast Cancer Biliary Cancer Colorectal Cancer

Start date: 2024-10-30
Primary completion: 2025-12-30
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.